Get started
UNITEDHEALTH GROUP INC CEDEAR EA 33 REP 1 COM(USD)UNITEDHEALTH GROUP INC CEDEAR EA 33 REP 1 COM(USD)UNITEDHEALTH GROUP INC CEDEAR EA 33 REP 1 COM(USD)

UNITEDHEALTH GROUP INC CEDEAR EA 33 REP 1 COM(USD)

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Seasonals Bonds

UNHD trade ideas

UNH: Why I Believe This Is a Dead Cat Bounce(Late posting)We’ve seen a quite the abounce in the market as of lately, but I believe it’s not a real recovery. To me, this looks like a classic dead cat bounce; a quick move up that happens during a downtrend before prices drop again. I’ll explain why I think this is the case, kind of a simple one. First of all, the grand picture in the economy still looks fairly negative, especially respecting the TRUMP TARIFF new. Inflation hasn’t fully gone away, interest rates are still high, and consumer confidence is weak. There’s no major change in the news or the fundamentals that would support a strong comeback. It feels like people are just hoping things will improve, but the facts don’t really support that yet. Second, the volume on this bounce has been low. In trading, volume tells you how strong a move is. If the price goes up but not many people are trading, it usually means there’s not much real buying happening. This bounce seems to be driven more by short sellers covering their positions, not by confident investors jumping in. Third, we’re hitting key resistance levels—areas where the price dropped before—and we’re starting to see signs of rejection again. These levels are often hard to break through unless the market has strong momentum, and right now it doesn’t look like that’s the case. Fourth, if you look at indicators like the RSI and MACD, they show that the price is already overbought. That means the recent move up may have gone too far, too fast. These kinds of readings usually lead to a pullback, especially when the bigger trend is still down. Finally, the overall structure of the chart hasn’t changed. We’re still making lower highs and lower lows, which is what a downtrend looks like. Just because we’ve had a few green candles doesn’t mean the trend has reversed. Until we see the market start building a base and making new highs with strong support, I don’t think this bounce will last. I n my opinion, this is one of those moments where people might get too excited too quickly. A lot of traders jump in thinking the bottom is in, only to get caught when the price turns back down. That’s why I’m staying cautious and watching for signs that the bounce is failing. I could be wrong, but right now, this feels more like a trap than a turning point.
NYSE:UNHShort
by ThePlotThickens
6
UNH Long Setup – Oversold Reversal PlayUnitedHealth ( NYSE:UNH ) is showing early signs of a potential bounce after a brutal selloff. 🔹 Price broke above the baseline (Ichimoku), first green candle close with bullish momentum 🔹 Williams %R showing oversold bounce from -80 levels 🔹 MACD turning positive on multiple timeframes 🔹 Clean risk/reward setup: ‣ Entry: $293 ‣ Target: $455 (55% upside) ‣ Stop: $249 (15% risk) ‣ R/R Ratio: 3.5+ This could be a high-reward reversal play if market strength continues. Watching closely for follow-through confirmation. #UNH #stocks #longsetup #tradingview #healthcare #swingtrade #technicalanalysis #chartsetup #Ichimoku
NYSE:UNHLong
by aaronkaltman
4
UNH LONGOh man, what a chart to dig into. (Read the fundamental analysis for this one—I don’t look into company financials or earnings. I’m also not following the news, so that’s on you. I’ve seen too many setups fail because of some unexpected headline or a random tweet on a f***ing Monday from the orange man.) Why am I looking at this setup? We’re sitting right at the 0.618 fib in a bullish trend. That lines up with the POC of a B-shaped volume profile, right at a support level. On top of that, liquidity under the trendline on the left has already been swept, and price is way overstretched from VWAP. So even if this isn’t a full reversal, we should at least get a pullback back toward the VWAP midline. entries at 301 283 264 SL at 236 TP 50% at 492, and let the rest rides There’s a lot going on here: Trend direction is still up. As long as we don’t get a close below 187, this is just a pullback. VWAP is miles away from the current price. Price doesn’t stay that far from it forever—it either pulls back or consolidates before heading higher. Fibs and TLs: There’s a major trendline (marked as Area 2) that hasn’t been touched for the third time yet. That same zone lines up with the 0.78 fib. Price hasn’t reached it yet—might not—but that’s still a spot I’d seriously consider for a long. POC zone: The marked long area is right on the POC of a B-profile. It’s a key level and should act as support. That’s a solid place to look for a bounce. I’ve marked out the setup and three possible entries. These are the spots I’d look to long from. If they all fail, then Area 2 is the backup—it should hold. One more thing: there’s a red line in the middle of the chart. If you want more confirmation, wait for price to close above it, then catch the retrace. That gives you more confidence in the setup. Do your own analysis and keep an eye on the news. TA only works if it lines up with the fundamentals. If not, it’s useless.
NYSE:UNHLong
by lojjkkjvvv
UNH watch $288-297: Double Golden zone a serious Long Term Buy?UNH keeps getting bad news but may have bottomed. Wave may have tested Double Golden fibs successfully. Looking for some consolidation then launch of recovery. $287.91-296.92 (Gold) is the key zone of interest. $382.05-384.18 (Red) is the first long term target. $251.94-255.83 (Green) is the MUST_HOLD bottom. . Previous Analysis that caught the top EXACTLY Follow and Boost to encourage more such PRECISE charts. ================================================== .
NYSE:UNH
by EuroMotif
4
Panic Creates Opportunity!- Corruption allegations and incidents like assassination have severely damaged the company. However, insider buying activity and a dramatic drop in valuation multiples create an exceptional opportunity. - The absence of issues in profitability or operational performance further reinforces this rare opportunity. - Negative analyst revisions have introduced political pressure on the company, which may persist. - Yet, those who invest when others are fearful often come out ahead. - The stock should be considered for swing trading. The price target aligns with two overlapping levels: the 61.8% retracement of the A-B-C correction wave, and the 261.8% projection of a post-correction 1-2-3-4-5 impulse wave (assuming wave 1 peak is fixed and wave 2 bottom is at the 61.8% level).
NYSE:UNHLong
by Tolgaun6
UNH Under Pressure – Below EMA 200 with Heavy Selling VolumeUNH (UnitedHealth) is showing clear bearish signs: Price has dropped below the EMA 200, a key long-term support level Recent sessions show strong selling volume, indicating institutional exit Trend is downward, with no bullish confirmation yet ⚠️ I stay cautious here — waiting for volume shift or price reclaim above EMA before considering a reversal. Until then, the bearish momentum stays active. Not financial advice – just my technical view. #UNH #StockAnalysis #BearishTrend #VolumeAnalysis #EMA200 #TechnicalTrading #HealthcareStocks
NYSE:UNH
by abdeljalillariam
UnitedHealth (UNH) Share Price ReboundsUnitedHealth (UNH) Share Price Rebounds A month ago, in our analysis of the UNH chart, we: → highlighted that UnitedHealth shares had lost nearly 23% in value; → drew a descending channel and suggested that bearish pressure could continue, threatening the support level around $450, which had held since early 2022. Since then, UNH’s stock price decisively broke below that level (as marked by the arrow), falling to around $250 — its lowest point since spring 2020 — before staging a sharp rebound. This steep price movement was driven by a series of fundamental developments, including: → the resignation of the CEO and news of a Department of Justice investigation into potential Medicare fraud; → UnitedHealth withdrawing its earnings guidance for the coming year; → political debates over the Medicaid programme as part of the 2025 budget negotiations; → President Trump’s directive to cut prescription drug prices. Recent news that the new CEO and several top executives have bought tens of millions of dollars’ worth of UNH shares appears to have renewed investor confidence — the share price rose above the $300 mark yesterday. Technical Analysis of UNH Share Chart These latest developments justify an update to the descending channel configuration. Of particular note is the gradual decline with limited volatility — a sign that the price is moving along the channel's median line (highlighted on the chart). In this setup: → the bounce from the $250 level points to the lower boundary of the channel; → traders may consider a scenario where the current recovery pushes UnitedHealth stock towards the median, after which supply pressure may return and offset the recent dominance of demand. It’s also possible that the key psychological level of $300 could now act as support. This article represents the opinion of the Companies operating under the FXOpen brand only. It is not to be construed as an offer, solicitation, or recommendation with respect to products and services provided by the Companies operating under the FXOpen brand, nor is it to be considered financial advice.
NYSE:UNH
by FXOpen
Generational Buy - Congratulations Well done to those that bought the dip on this below $300. I filled 80% of my position at $250 - the Point of Control according to the highest volume node. We had a capitulation in the top healthcare insurer. Absolute peak fear given the long list of events which culminated in the CEO leaving. His departure could have been the final flush out as holders capitulated. This presented a unique opportunity to get in on an undervalued stock trading at a P/E of 11.1. I’m a trader, so I won’t comment on the ethics of this company, it’s beyond the scope of my work. Technically I expect this relief rally to continue but in a corrective fashion with a potential resistance level looming. The 5th wave ending is normally followed by an abc correction, wave A has concluded, wave B is in play so I expect onward bullish recovery. For confluence, the weekly RSI had a complete reset hitting level of 30, the most oversold in many years. My indicator has flashed green (buy) so $250 could have been a generational low. None of this is financial advice, I got in at a good entry and I have a stop loss in place if this poops the bed again.
NYSE:UNHLong
by NoFOMO_
Not All Hype = Opportunity | UnitedHealth $UNH Analysis Lately, I’ve been seeing a lot of chatter about buying NYSE:UNH — UnitedHealth Group — as if it’s the “big opportunity” after the drop… But let’s keep it real — the chart isn’t confirming that yet. 👀 Take a close look 👇 Price completely broke structure from previous highs around $630. The recent drop was aggressive, and there's no clean retest or setup forming yet. Unlike NASDAQ:MSTR (MicroStrategy), which gave us a structured pullback and liquidity sweep, NYSE:UNH still looks like it has more downside to go. ⚠️ I’m not rushing in because the news or a rumor says “buy now.” I’d rather wait for a clearer structure, a lower low, and a reaction from a real demand zone — just like the example I marked on MicroStrategy. This is a great reminder: Let price tell you when it's time — not social media hype. For now, NYSE:UNH goes on the watchlist, not the buy list. 📉🧠
NYSE:UNHShort
by MoNi_MoN
UNH | Catching the Fall Risky Play💊 Oversold Swing Play ⚠️ Risk Factor You're not trading a bounce—you’re stepping into a fire. Legal risk + uncertainty = extreme volatility. However, if markets stabilize, UNH could deliver a powerful mean-reversion move. UnitedHealth ( NYSE:UNH ) is trading in panic territory after: DOJ launched a criminal probe tied to Medicare Advantage billing Abrupt CEO resignation Suspended 2025 financial guidance, sparking investor selloff Still, the fundamentals aren’t dead. Q1 revenue is strong, and long-term value is on the table. 🎯 Trade Plan 🟢 Entry Zones 🔹 Zone 1: $275–$285 → Technical support + RSI oversold 🔹 Zone 2: $255 → 2021 breakout retest 🔹 Zone 3: $225 → Ultimate fear zone (deep capitulation possible) 💰 Profit Targets ✅ TP1: $300 – Psychological level & minor resistance ✅ TP2: $340 – Gap-fill area & 50-day MA ✅ TP3: $385+ – Long-term value zone if sentiment reverses 📌 Final Word UNH is no penny stock—it’s a $280B giant under siege. If you believe fear is overdone, this is a calculated shot at a rebound. Just keep your stops tight and your thesis tighter. 🚨 Disclaimer: This is not financial advice. Trading involves risk. Always DYOR and manage your exposure carefully.
NYSE:UNHLong
by Robert_V12
2